Filing summary
Filing identity: The supplied filing is Nanometrics Incorporated’s Form 10-Q for the quarter ended September 27, 2014—not an Onto Innovation filing for 2012 Q3. The company and period in the request metadata do not match the filing.
Business context and reporting period
Nanometrics designs, manufactures and supports metrology and inspection systems used primarily in semiconductor manufacturing. This unaudited report covers the three- and nine-month periods ended September 27, 2014, compared with the periods ended September 28, 2013.
Financial performance and liquidity
| Metric | Q3 2014 | Q3 2013 | Nine months 2014 | Nine months 2013 |
|---|---|---|---|---|
| Revenue | $27.1 million | $39.0 million | $126.7 million | $98.1 million |
| Gross profit | $11.4 million | $15.8 million | $58.5 million | $40.8 million |
| Operating income (loss) | $(10.6) million | $(7.2) million | $(7.8) million | $(23.0) million |
| Net income (loss) | $(28.7) million | $(4.6) million | $(26.5) million | $(14.7) million |
| Operating cash flow | Not provided for quarter | Not provided for quarter | $(9.5) million | $(3.9) million |
Q3 gross margin was approximately 42.1%, versus 40.5%; nine-month gross margin was approximately 46.1%, versus 41.5%. Product gross margin improved year over year, while service gross margin declined. The Q3 net loss included a $17.9 million tax provision, principally reflecting a one-time $21.1 million valuation allowance against U.S. deferred tax assets.
At September 27, 2014, cash and cash equivalents were $35.6 million and marketable securities were $48.7 million, totaling $84.4 million. Working capital was $130.2 million. The company had no drawn line-of-credit balance and reported $15.9 million of borrowing availability; it reported no outstanding mortgage debt. Total liabilities were $37.0 million and stockholders’ equity was $189.9 million.
Material changes versus the prior comparable periods
- Q3 revenue declined 31% year over year, primarily due to a pause in spending by the two largest customers. Product revenue fell 35% and service revenue fell 14%.
- Nine-month revenue increased 29%, mainly due to stronger memory-related semiconductor spending and greater foundry penetration. Product revenue rose 46%, while service revenue fell 13%.
- Q3 operating loss widened despite lower operating expenses; the nine-month operating loss narrowed substantially from 2013.
- Nine-month operating cash use increased to $9.5 million from $3.9 million, including a $16.3 million reduction in deferred revenue and higher inventory.
- Cash, cash equivalents and marketable securities decreased from $92.9 million at December 28, 2013 to $84.4 million at quarter-end.
Outlook, risks and unusual items
- Management stated that existing cash, investments, expected operating cash flow and available borrowing were expected to meet liquidity needs for at least the next 12 months. The filing provides no specific revenue or earnings guidance.
- The company recorded a $1.7 million restructuring charge to consolidate part of its U.K. operations, including facility termination costs; completion was expected by March 2015.
- Customer and industry spending, product mix, new-product adoption, and order, shipment and acceptance timing can materially affect results. The semiconductor equipment market is cyclical.
- Customer concentration is significant: one customer represented 28% of nine-month revenue. SK Hynix represented 26% of accounts receivable at quarter-end.
- Deferred tax asset realization depends on future taxable income; the company cited cumulative U.S. losses as negative evidence and maintained valuation allowances on certain foreign deferred tax assets.
- The company reported no material change in risk factors from its 2013 Form 10-K and no off-balance-sheet arrangements. Management concluded disclosure controls were effective; a new ERP system had been implemented in Q1 2014.
Important facts for investors to verify
- Confirm the intended issuer and period: this source is Nanometrics Incorporated, Q3 2014, not Onto Innovation, Q3 2012.
- Review the $21.1 million U.S. deferred-tax-asset valuation allowance and the evidence needed for any future reversal.
- Track customer spending and concentration, particularly the largest customer and SK Hynix.
- Assess whether revenue recovery converts into operating cash flow, given the nine-month cash use and decline in deferred revenue.
- Monitor execution and remaining costs of the U.K. restructuring, as well as the $15.9 million revolver availability and its tangible-net-worth covenant.